Friday, June 19, 2026
🇺🇸 FDA

pharma · Acute Myeloid Leukemia · Breast Cancer

First People's Hospital

The First People's Hospital of Lianyungang

First People's Hospital clinical programs — 1136 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
SAN DIEGO, CA, CN
Programs
1136
Drugs
626
Patents
123
All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

First People's Hospital projects

1,136 ClinicalTrials.gov programs sponsored by First People's Hospital.

First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,136 programs

Clinical programs

Page 2 of 24

  1. Ketorolac

    The First People's Hospital of Lianyungang

    Aortic Dissection

    phase 3 small molecule active

    1 trial

  2. Keverprazan Hydrochloride tablets + high dose amoxicillin

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education

    phase 3 small molecule active

    1 trial

  3. Lenvatinib

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    phase 3 small molecule terminated

    1 trial

  4. Letrozole

    The First People's Hospital of Lianyungang

    Polycystic Ovary Syndrome

    phase 3 small molecule completed

    1 trial

  5. Megestrol（Yining）

    The First People's Hospital of Lianyungang

    Stage III Esophageal Squamous Cell Carcinoma

    phase 3 small molecule completed

    1 trial

  6. Metformin plus pioglitazone

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  7. Methylprednisolone pulse

    The First People's Hospital of Lianyungang

    Glomerulonephritis, IGA

    phase 3 small molecule terminated

    1 trial

  8. Methylprednisolone sodium succinate

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  9. Mimetic granules of Yiqi-Wenjing prescriptions

    The First People's Hospital of Lianyungang

    Chemotherapy-induced Peripheral Neuropathy

    phase 3 small molecule active

    1 trial

  10. Mitoxantrone Hydrochloride Liposome

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule active

    1 trial

  11. N-Acetylcysteine

    The First People's Hospital of Lianyungang

    Thrombotic Microangiopathies

    phase 3 small molecule completed

    1 trial

  12. N-Acetylcysteine (NAC) Treatment

    The First People's Hospital of Lianyungang

    Thrombotic Microangiopathy

    phase 3 small molecule active

    1 trial

  13. Nedaplatin

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 3 small molecule completed

    1 trial

  14. Nimotuzumab

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  15. Normal Saline

    The First People's Hospital of Lianyungang

    Postoperative Sleep Disturbance

    phase 3 small molecule active

    1 trial

  16. Osimertinib

    The First People's Hospital of Lianyungang

    Non-small Cell Carcinoma

    phase 3 small molecule active

    1 trial

  17. Oxaliplatin

    The First People's Hospital of Lianyungang

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  18. Paclitaxel

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 small molecule active

    1 trial

  19. Paclitaxel or docetaxel + Cisplatin or carboplatin

    The First People's Hospital of Lianyungang

    Uterine Cervical Neoplasms

    phase 3 small molecule active

    1 trial

  20. Paclitaxel, Cisplatin Plus 5-FU (TCF)

    The First People's Hospital of Lianyungang

    Esophageal Cancer Stage IIB

    phase 3 other active

    1 trial

  21. Pembrolizumab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 3 mab active

    1 trial

  22. Realgar-Indigo naturalis formula

    The First People's Hospital of Lianyungang

    Acute Promyelocytic Leukemia

    phase 3 small molecule active

    1 trial

  23. Recombinant Human Albumin Injection

    The First People's Hospital of Lianyungang

    Hepatic Ascites

    phase 3 mab completed

    2 trials

  24. Recombinant Human Thrombopoietin (rhTPO)

    The First People's Hospital of Lianyungang

    Immune Thrombocytopenia

    phase 3 small molecule completed

    1 trial

  25. Remdesivir

    The First People's Hospital of Lianyungang

    Covid19

    phase 3 small molecule active

    1 trial

  26. Remimazolam Besylate

    The First People's Hospital of Lianyungang

    Critical Illness; Mechanical Ventilation; Shock

    phase 3 small molecule active

    1 trial

  27. Rifaximin

    The First People's Hospital of Lianyungang

    Crohn Disease

    phase 3 small molecule active

    1 trial

  28. Rituximab

    The First People's Hospital of Lianyungang

    Diffuse Large B-cell Lymphoma

    phase 3 small molecule active

    3 trials

  29. Rituximab

    The First People's Hospital of Lianyungang

    Refractory Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  30. Robotic Gastrectomy

    The First People's Hospital of Lianyungang

    Gastric Cancer (GC)

    phase 3 other active

    1 trial

  31. S-1 therapy

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule active

    1 trial

  32. SL-B2022-793-01

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  33. Sorafenib

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  34. Suxiao Jiuxin Pill

    The First People's Hospital of Lianyungang

    Acute Mountain Sickness

    phase 3 small molecule active

    1 trial

  35. TNK-tPA

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  36. The methylprednisolone sodium succinate

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  37. Tiaoshen Anti-cancer Granules

    The First People's Hospital of Lianyungang

    Ovarian Neoplasms Malignant

    phase 3 small molecule active

    1 trial

  38. Tinidazole oral microneedle patch

    The First People's Hospital of Lianyungang

    Evaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis

    phase 3 other active

    1 trial

  39. Tislelizumab

    The First People's Hospital of Lianyungang

    Rectal Neoplasms

    phase 3 small molecule active

    1 trial

  40. Tislelizumab + SOX Chemotherapy

    The First People's Hospital of Lianyungang

    Gastric Cancer Stage III

    phase 3 small molecule active

    1 trial

  41. Tranexamic acid

    The First People's Hospital of Lianyungang

    Hemorrhage, Postpartum

    phase 3 small molecule completed

    1 trial

  42. Triptorelin for Injection

    The First People's Hospital of Lianyungang

    Ovarian Hyperstimulation Syndrome

    phase 3 small molecule active

    1 trial

  43. Trophic enteral feeding combined with supplemental parenteral nutrition

    The First People's Hospital of Lianyungang

    Severe Stroke

    phase 3 other active

    1 trial

  44. Two Anti-angiogenesis Drugs（Endostar and Thalidomide）

    The First People's Hospital of Lianyungang

    Colorectal Neoplasms

    phase 3 small molecule active

    1 trial

  45. Tyrosine kinase inhibitor (TKIs)

    The First People's Hospital of Lianyungang

    Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  46. UDCA

    The First People's Hospital of Lianyungang

    Diabetes Mellitus

    phase 3 small molecule active

    1 trial

  47. Ustekinumab

    The First People's Hospital of Lianyungang

    Crohn Disease

    phase 3 small molecule active

    1 trial

  48. Venetoclax

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does First People's Hospital have?

1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.